Researchers leading the largest
genomic tumor profiling effort of its kind say such studies are technically feasible in a broad population of adult and pediatric patients with many different types of cancer, and that some patients can benefit by receiving precision drugs targeted to their tumors» mutations or being enrolled in clinical trials.
The 15 AACR scientists, who were already in Washington, D.C., to meet with the U.S. Food and Drug Administration on genetic testing for cancer patients, tossed around ideas including expanding NCI's tumor genome - sequencing efforts and getting the government to cover the costs of
genomic tumor profiling.
Not exact matches
Traditional genetic approaches together with the new wealth of
genomic information for both human and model organisms open up strategies by which drugs can be
profiled for their ability to selectively kill cells in a molecular context that matches those found in
tumors.
The study —
Genomic profiles of low - grade murine gliomas evolve during progression to glioblastoma — published April 7, shows how these
tumors continue to rapidly evolve, becoming ever more genetically diverse, as they become malignant and progress.
Researchers developed models to examine the influence of driver mutations — mutations that promote cancer development — on the initiation and development of gliomas, and how
tumor genomic profiles evolve as the cancer progresses.
Utilizing
tumors from a
genomic analysis clinical trial at Rutgers Cancer Institute examining rare cancers and those that respond poorly to standard care, 97
tumors with the P13K / AKT / mTOR pathway were
profiled.
Research from Rutgers Cancer Institute of New Jersey examining difficult to treat cancer
tumors through
genomic profiling shows that
tumors with alterations in a signaling pathway responsible for cell regulation may respond to targeted therapy regardless of where the
tumor originated in the body.
The study wasn't designed to measure whether
tumor profiling made a difference in how patients fared, but «it nonetheless lays the groundwork for more systematic study of the impact of
genomics on clinical practice and patient outcomes,» the report said.
The fact that she has found them to be differentially regulated in angiosarcoma
tumors has led to the hypothesis that there are epigenetic regulators of these genes that have yet to be identified through the
genomic profiling applied to these studies thus far.
Single - cell DNA solid
tumor profiling enables high resolution of the
genomic diversity in a variety of
tumor types.
Our groundbreaking Pediatric Mi - Oncoseq Program is an internationally known precision oncology program focusing on the genetic analysis of pediatric cancer patients including in children with malignant brain
tumors, and determines whether targeted treatments may be available based upon their personalized
tumor genomic sequencing
profiles.
To determine the genetic
profile of a patient's
tumor and identify cancer - driving genes, our team of experts uses advanced
genomic sequencing technology.
Examples include the study of allelic variation in the human genome and the development of computational methods for the discovery of cancer - associated genes and diagnostic cancer markers using
genomic profiles derived from different
tumor types.